Literature DB >> 25299715

Inhibition of brain citrate synthase activity in an animal model of sepsis.

Giselli Scaini1, Natália Rochi1, Joana Benedet1, Gabriela Kozuchovski Ferreira1, Brena Pereira Teodorak1, Clarissa Martinelli Comim2, Larissa de Souza Constantino1, Francieli Vuolo1, Leandra Celso Constantino2, João Quevedo2, Emilio Luiz Streck1, Felipe Dal-Pizzol1.   

Abstract

OBJECTIVE: An extensive body of evidence from experimental studies indicates that sepsis is associated with increased reactive oxygen species production, depletion of antioxidants, and accumulation of markers of oxidative stress. Moreover, mitochondrial dysfunction has been implicated in the pathogenesis of multiple organ dysfunction syndrome (MODS). Citrate synthase is an enzyme localized in the mitochondrial matrix and an important component of the Krebs cycle; consequently, citrate synthase has been used as a quantitative enzyme marker for the presence of intact mitochondria. Thus, we investigated citrate synthase activity in the brains of rats submitted to a cecal ligation puncture model of sepsis.
METHODS: At several times points (3, 6, 12, 24 and 48 hours) after the cecal ligation puncture operation, six rats were killed by decapitation. Their brains were removed, and the hippocampus, striatum, cerebellum, cerebral cortex and prefrontal cortex were dissected and used to determine citrate synthase activity.
RESULTS: We found that citrate synthase activity in the prefrontal cortex was inhibited 12, 24 and 48 hours after cecal ligation puncture. In the cerebral cortex, citrate synthase activity was inhibited 3, 12, 24 and 48 hours after cecal ligation puncture. Citrate synthase was not affected in the hippocampus, striatum or cerebellum up to 48 hours after cecal ligation puncture.
CONCLUSION: Considering that energy impairment due to mitochondrial dysfunction in sepsis has been well described and that oxidative stress plays a crucial role in sepsis development, we believe that energy impairment may also be involved in these processes. If citrate synthase inhibition also occurs in a sepsis model, it is tempting to speculate that a reduction in brain metabolism may be related to the pathophysiology of this disease.

Entities:  

Year:  2011        PMID: 25299715

Source DB:  PubMed          Journal:  Rev Bras Ter Intensiva        ISSN: 0103-507X


  4 in total

1.  Atorvastatin Relieves Cognitive Disorder After Sepsis Through Reverting Inflammatory Cytokines, Oxidative Stress, and Neuronal Apoptosis in Hippocampus.

Authors:  Jianmei Tian; Yongjie Tai; Mengrao Shi; Chunxiu Zhao; Wenwen Xu; Xuhua Ge; Guoji Zhu
Journal:  Cell Mol Neurobiol       Date:  2019-11-06       Impact factor: 5.046

2.  Diabetes Exacerbates Sepsis-Induced Neuroinflammation and Brain Mitochondrial Dysfunction.

Authors:  Solange de Souza Stork; Marcos Hübner; Erica Biehl; Lucineia Gainski Danielski; Sandra Bonfante; Larissa Joaquim; Tais Denicol; Thaina Cidreira; Anita Pacheco; Erick Bagio; Everton Lanzzarin; Gabriela Bernades; Mariana Pacheco de Oliveira; Larissa Espindola da Silva; Josiel M Mack; Franciane Bobinski; Gislaine Tezza Rezin; Tatiana Barichello; Emilio Luiz Streck; Fabricia Petronilho
Journal:  Inflammation       Date:  2022-06-10       Impact factor: 4.092

3.  Enhanced Muscle Strength in Dyslipidemic Mice and Its Relation to Increased Capacity for Fatty Acid Oxidation.

Authors:  Marta Tomczyk; Alicja Braczko; Patrycja Jablonska; Adriana Mika; Kamil Przyborowski; Agata Jedrzejewska; Oliwia Krol; Filip Kus; Tomasz Sledzinski; Stefan Chlopicki; Ewa M Slominska; Ryszard T Smolenski
Journal:  Int J Mol Sci       Date:  2021-11-12       Impact factor: 5.923

4.  Rosiglitazone Ameliorates Cardiac and Skeletal Muscle Dysfunction by Correction of Energetics in Huntington's Disease.

Authors:  Marta Tomczyk; Alicja Braczko; Paulina Mierzejewska; Magdalena Podlacha; Oliwia Krol; Patrycja Jablonska; Agata Jedrzejewska; Karolina Pierzynowska; Grzegorz Wegrzyn; Ewa M Slominska; Ryszard T Smolenski
Journal:  Cells       Date:  2022-08-27       Impact factor: 7.666

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.